Despite insufficient data about the role of ACE2 in COVID-19 associated complications, soluble ACE2 is thought to have protective effects on a pulmonary form of the disease not only by its anti-inflammatory and anti-remodeling properties but importantly by exhibiting an anti-aggregant activity, which is important for the survival of hospitalized COVID-19 patients. The gene discussed is ACE2; the disease is COVID-19.